Urogenital Fistula - Causes, Treatment & When to See a Doctor

```html

What is Urogenital Fistula?

A ureogenital fistula (also spelled urogenital fistula) is an abnormal passage that forms between any part of the urinary tract (bladder, ureters, urethra) and the genital tract (vagina, uterus, or perineum). When the fistula is present, urine (and sometimes feces, if the tract also involves the intestine) can leak into an area where it does not belong, causing continuous wetness, irritation, and a strong odor.

These fistulas are most often classified by the two structures they connect, for example:

• Vesicovaginal fistula – bladder ↔ vagina
• Urethrovaginal fistula – urethra ↔ vagina
• Ureterovaginal fistula – ureter ↔ vagina
• Rectourethral or rectovaginal fistula – intestine ↔ urinary tract (these are sometimes grouped under “urogenital” because urine leaks into the rectal or vaginal canal).

In low‑resource settings, obstetric injury remains a leading cause, whereas in high‑income countries surgical complications, radiation therapy, and malignancy are more common. Early recognition and treatment are essential to prevent chronic infection, psychological distress, and social isolation.

Common Causes

Below are the most frequent conditions or events that can lead to a urogenital fistula. Many are preventable with proper obstetric care, surgical technique, or early disease management.

• Obstetric trauma: prolonged or obstructed labor leading to tissue necrosis, especially in regions where emergency cesarean section is not promptly available.
• Pelvic surgery: hysterectomy, bladder or urethral surgery, and repair of prolapse can unintentionally create a tract.
• Radiation therapy: treatment for cervical, bladder, or rectal cancer damages local tissues and can cause delayed fistula formation.
• Malignancy: invasive cancers of the cervix, bladder, vagina, or rectum can erode into adjacent organs.
• Congenital anomalies: rare developmental defects such as cloacal malformations or persistent urachal fistulas.
• Traumatic injury: pelvic fractures, gunshot wounds, or severe blunt trauma to the perineum.
• Infections: severe urinary tract infections, tuberculosis of the genital tract, or chronic sexually transmitted infections that lead to tissue breakdown.
• Foreign bodies: prolonged use of vaginal or urinary catheters, pessaries, or retained surgical sponges.
• Inflammatory bowel disease (IBD): Crohn’s disease can cause fistulizing lesions that involve the urinary tract.
• Diverticular disease or diverticulitis: perforation near the bladder or urethra may create a fistula.

Associated Symptoms

Symptoms vary depending on the fistula’s location, size, and whether it is “pure” (urine only) or combined with fecal leakage.

• Continuous or intermittent urinary leakage from the vagina or perineum.
• Unexplained vaginal wetness or “wet” underwear despite normal bladder emptying.
• Foul odor, especially if fecal material is present.
• Pain or burning during urination (dysuria) or after intercourse (dyspareunia).
• Recurrent urinary tract infections (UTIs) or vaginal infections.
• Pelvic pressure or a sense of fullness.
• Hematuria (blood in urine) if the fistula is associated with malignancy or radiation injury.
• Difficulty controlling bowel movements if a rectovaginal component exists.
• Emotional distress, social isolation, and embarrassment due to ongoing leakage.

When to See a Doctor

Prompt medical evaluation is advised whenever any of the following occur:

• Persistent leakage of urine or fluid from the vagina, perineum, or anus.
• Sudden onset of leakage after childbirth, surgery, or a pelvic injury.
• Recurrent UTIs that do not improve with standard antibiotics.
• Bleeding from the urinary or genital tract that does not resolve.
• Painful urination, pelvic pain, or painful intercourse that interferes with daily activities.
• Fever, chills, or foul-smelling discharge suggesting infection.

Even if the leakage seems “minor,” a specialist (urogynecologist, urologist, or colorectal surgeon) should be consulted because early repair leads to higher success rates and fewer complications.

Diagnosis

Diagnosing a urogenital fistula involves a step‑wise approach to confirm the presence, locate the tract, and assess the surrounding tissue.

1. Medical History & Physical Exam

• Detailed obstetric, surgical, and radiation history.
• Inspection of the perineum and vagina with a speculum while the patient coughs or performs a Valsalva maneuver to demonstrate leakage.
• Palpation of the bladder and assessment of pelvic floor tone.

2. Imaging Studies

• Void‑cystography (VCUG): X‑ray taken while the bladder is filled with contrast; shows leakage pathways.
• CT urography or MR urography: Provides detailed cross‑sectional images—useful for complex or high‑located fistulas.
• Ultrasound: Trans‑vaginal or trans‑abdominal scans can identify fluid collections and guide further testing.
• Fistulography: Direct injection of contrast into the suspected fistula tract.

3. Endoscopic Evaluation

• Cystoscopy: Camera inside the bladder to locate the internal opening.
• Ureteroscopy: If ureteral involvement is suspected.
• Colonoscopy or sigmoidoscopy: When a rectal component is possible.

4. Specialized Tests

• Pelvic floor pressure studies (urodynamics) to assess bladder function.
• Biopsy of surrounding tissue if malignancy is a concern.

Treatment Options

Management is individualized based on fistula size, location, patient health, and whether the fistula is “fresh” (≤3 months) or chronic.

Conservative / Medical Management

• Catheter drainage: Indwelling Foley catheter for 2–4 weeks can allow small (<5 mm) fistulas to close spontaneously.
• Antibiotics: Treat concurrent UTIs or vaginal infections; culture‑directed therapy is recommended.
• Estrogen therapy: Post‑menopausal women may benefit from topical estrogen to improve vaginal tissue quality before surgery.
inter Nutrition optimization: Adequate protein, vitamin C, zinc, and iron support tissue healing.

Surgical Repair

Most fistulas ultimately require surgery. The goal is to close the tract in a well‑vascularized, tension‑free layer and protect it with tissue interposition when needed.

• Trans‑vaginal approach: Preferred for low‑lying vesicovaginal or urethrovaginal fistulas; avoids abdominal incision.
• Trans‑abdominal (open or laparoscopic) approach: Used for high‑located fistulas, large defects, or when concomitant bowel repair is required.
• Robotic‑assisted repair: Provides 3‑D visualization and precise suturing for complex cases; outcomes comparable to open surgery.
• Tissue interposition flaps: Martius (bulbocavernosus) flap, omental flap, or peritoneal flap are placed between urinary and genital closures to improve blood supply.
• Staged repair: In radiation‑induced or infected fields, a temporary diverting urinary stent (nephrostomy or suprapubic catheter) may be placed first, followed by definitive repair after inflammation subsides.

Success rates range from 80‑95 % for uncomplicated fistulas, but repeat surgery may be required for larger or radiation‑related defects.

Post‑operative Care

• Continuous bladder drainage for 10–14 days (or longer) to reduce pressure on the repair.
• Pelvic floor physiotherapy once healing is confirmed.
• Strict hygiene, cotton under‑garments, and barrier creams to protect skin.
• Follow‑up imaging (cystogram) before catheter removal.

Home & Lifestyle Measures (Adjunctive)

• Maintain adequate hydration (1.5–2 L/day) to keep urine dilute.
• Avoid constipation: high‑fiber diet, stool softeners if needed—reduces pressure on pelvic repairs.
• Use breathable, moisture‑wicking underwear; change frequently to prevent skin breakdown.
• Stress‑incontinence pads may be useful temporarily, but they do not treat the fistula.

Prevention Tips

While not all fistulas are preventable, many risk factors are modifiable:

• Skilled obstetric care: Early recognition of obstructed labor and timely cesarean delivery dramatically lower vesicovaginal fistula rates.
• Elective surgical planning: Use of intra‑operative cystoscopy during gynecologic surgery to confirm bladder integrity.
• Radiation safety: Precise dosing, use of intensity‑modulated radiation therapy (IMRT), and protective shielding when treating pelvic malignancies.
• Prompt treatment of infections: Early antibiotics for severe urinary or genital infections, especially in immunocompromised patients.
• Management of chronic diseases: Good control of diabetes, IBD, and TB reduces tissue breakdown.
• Catheter hygiene: Replace indwelling catheters no longer than 2 weeks, keep the area clean, and use the smallest catheter size possible.
• Pelvic floor health: Regular Kegel exercises and physiotherapy to maintain muscle tone and support surrounding structures.
• Nutrition: Adequate protein (0.8–1 g/kg body weight) and micronutrients support tissue integrity.
• Regular prenatal care: Early detection of high‑risk pregnancies can prevent obstructed labor.

Emergency Warning Signs

If any of the following occur, seek emergency medical care (go to the nearest emergency department or call emergency services):

• Sudden, profuse urinary leakage combined with severe lower‑abdominal or pelvic pain.
• Fever > 38.5 °C (101.3 °F) with chills, suggesting a serious infection or sepsis.
• Visible blood clots in urine or vaginal discharge, especially after trauma or surgery.
• Inability to pass urine (urinary retention) or a painful, distended bladder.
• Signs of bowel obstruction (vomiting, abdominal swelling) when a fistula involves the rectum.
• Rapidly worsening skin breakdown or ulceration around the fistula site.

Timely evaluation can prevent life‑threatening complications and improve the chances of a successful repair.

---

References:

• Mayo Clinic. “Vesicovaginal fistula.” Mayo Clinic Proceedings, 2022.
• World Health Organization. “Obstetric fistula: report of a WHO Technical Consultation.” WHO, 2020.
• American Urological Association. “Guidelines for the Management of Female Urinary Incontinence.” 2021.
• Cleveland Clinic. “Urogenital Fistulas – Causes, Symptoms, and Treatment.” 2023.
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Crohn’s Disease and Fistulas.” 2021.
• International Society of Urogynecology. “Management of Obstetric Fistulas.” 2022.

```